Sign in to confirm you’re not a bot
This helps protect our community. Learn more

PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD

La Jolla Institute for Immunology
1.66K subscribers
<__slot-el>
<__slot-el>
8.7K views 2 years ago #Oncology #STEM #Cancer
Gordon Freeman, PhD. Professor of Medicine, Harvard Medical School Host: Patrick Hogan A fascinating look at what’s new in cancer immunology research and Dr. Freeman’s findings regarding B7-1 and B7-2 proteins. A closer look at advances in checkpoint inhibitor / blockage approaches. Seminar hosted by La Jolla Institute for Immunology in San Diego, CA. #STEM #STEMCareers #Cancer #Oncology #CancerTherapies #Immunotherapies www.lji.org ...more
...more
PD-L1/PD-1 Cancer Immunotherapy and New Targets - Gordon Freeman, PhD
118Likes
8,776Views
2022Oct 17
Gordon Freeman, PhD. Professor of Medicine, Harvard Medical School Host: Patrick Hogan A fascinating look at what’s new in cancer immunology research and Dr. Freeman’s findings regarding B7-1 and B7-2 proteins. A closer look at advances in checkpoint inhibitor / blockage approaches. Seminar hosted by La Jolla Institute for Immunology in San Diego, CA. #STEM #STEMCareers #Cancer #Oncology #CancerTherapies #Immunotherapies www.lji.org

Follow along using the transcript.

La Jolla Institute for Immunology

1.66K subscribers